Evidence-based clinical practice guidelines for IgA nephropathy 2014
Clin Exp Nephrol
.
2016 Aug;20(4):511-535.
doi: 10.1007/s10157-015-1223-y.
Authors
Yukio Yuzawa
1
,
Ryohei Yamamoto
2
,
Kazuo Takahashi
3
,
Ritsuko Katafuchi
4
,
Makoto Tomita
3
,
Yoshihide Fujigaki
5
,
Hiroshi Kitamura
6
,
Masashi Goto
7
,
Takashi Yasuda
8
,
Mitsuhiro Sato
9
,
Maki Urushihara
10
,
Shuji Kondo
10
,
Shoji Kagami
10
,
Yoshinari Yasuda
11
,
Hiroyuki Komatsu
12
,
Miki Takahara
13
,
Yasuaki Harabuchi
13
,
Kenjiro Kimura
14
,
Seiichi Matsuo
11
Affiliations
1
Fujita Health University School of Medicine, Toyoake, Japan.
[email protected]
.
2
Osaka University Graduate School of Medicine, Suita, Japan.
3
Fujita Health University School of Medicine, Toyoake, Japan.
4
National Fukuoka-Higashi Medical Center, Koga, Japan.
5
Teikyo University School of Medicine, Tokyo, Japan.
6
Chiba East Hospital, Chiba, Japan.
7
Kyoto Medical Center, Kyoto, Japan.
8
Kichijoji Asahi Hospital, Tokyo, Japan.
9
JCHO Sendai Hospital, Sendai, Japan.
10
Tokushima University Graduate School, Tokushima, Japan.
11
Nagoya University Graduate School of Medicine, Nagoya, Japan.
12
University of Miyazaki Hospital, Miyazaki, Japan.
13
Asahikawa Medical University, Asahikawa, Japan.
14
St. Marianna University School of Medicine, Kawasaki, Japan.
PMID:
27095365
PMCID:
PMC4956709
DOI:
10.1007/s10157-015-1223-y
No abstract available
Publication types
Practice Guideline
MeSH terms
Evidence-Based Medicine
Glomerulonephritis, IGA / diagnosis
Glomerulonephritis, IGA / etiology
Glomerulonephritis, IGA / therapy*
Humans